SoundHound AI Inc vs Tempus AI — how do they compare? SoundHound AI Inc trades at $5.6 (market cap $2.45B), while Tempus AI trades at $70.25 (market cap $12.58B). The key difference: Tempus AI is far larger — about 5.1× SoundHound AI Inc's market cap, and Tempus AI is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SoundHound AI Inc for 23 Days and Tempus AI for 22 Days on average.
| SOUN | TEM | |
|---|---|---|
Market Cap | $2.45B | $12.58B |
Volume | 16,881,989 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $21.40 | $99.28 |
52-Week Low | $5.52 | $41.55 |
Typical Hold Time | 23 Days | 22 Days |
Enterprise Value | $2.25B | $13.21B |
Signals from Pluang's Aura AI — not financial advice
SoundHound AI (SOUN) trades at $5.63, down 1.57% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth ($169M in 2025, projected $203M in 2026) but significant net losses (-$14M in 2025, -$137M projected in 2026). Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch for vehicles and smart devices (GlobeNewsWire, September 24, 2026).
Investment outlook balances high growth potential against substantial profitability challenges. Analyst consensus is bullish with a $9.33 price target (75% buy ratings), but negative cash flow from operations and insider selling pose near-term risks. The stock's success depends on converting revenue growth to profitability while managing integration risks from acquisitions.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →